BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10150262)

  • 21. [Clinical results with sulbactam/ampicillin in a multicenter study of 425 patients].
    Lode H; Springsklee M
    Med Klin (Munich); 1989 May; 84(5):236-41. PubMed ID: 2661984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.
    Falagas ME; Barefoot L; Griffith J; Ruthazar R; Snydman DR
    Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):913-21. PubMed ID: 9031873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An open comparative study of sulbactam/ampicillin vs mezlocillin in adult and pediatric patients. Efficacy and tolerability].
    Chiodo F; Manfredi R; Zucchini A
    Minerva Med; 1991 Jun; 82(6):387-94. PubMed ID: 2067712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bactericidal activity of low-dose ceftizoxime plus metronidazole compared with cefoxitin and ampicillin-sulbactam.
    Freeman CD; Nightingale CH; Nicolau DP; Belliveau PP; Tessier PR; Fu Q; Xuan DW; Quintiliani R
    Pharmacotherapy; 1994; 14(2):185-90. PubMed ID: 8197037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sulbactam/ampicillin in comparison with cefuroxime for infections of the lower respiratory tract. Results of a prospective, randomized comparative study].
    Schwigon CD; Cuhorst R; Gabor M; Zinndorf J; Springsklee M
    Med Klin (Munich); 1993 Jan; 88(1):16-20. PubMed ID: 8437527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion of treatment from cefoxitin to ampicillin/sulbactam: experience in a university teaching hospital.
    Kitrenos JG; Rotella DL; Nakasato S
    Adv Ther; 1995; 12(1):30-43. PubMed ID: 10150321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-dose ampicillin/sulbactam versus ceftriaxone as treatment for uncomplicated gonorrhoea in a Ugandan STD clinic population with a high prevalence of PPNG infection.
    Hellmann NS; Nsubuga PS; Baingana-Baingi DJ; Desmond-Hellmann SD; Mbidde EK; Granowitz CB; Sande MA
    J Trop Med Hyg; 1995 Apr; 98(2):95-100. PubMed ID: 7714943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic prophylaxis in transurethral surgery: a comparison of sulbactam-ampicillin and cefoxitin.
    Dørflinger T; Madsen PO
    Infection; 1985; 13(2):66-9. PubMed ID: 2987133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early postpartum endometritis. Randomized comparison of ampicillin/sulbactam vs. ampicillin, gentamicin and clindamycin.
    Resnik E; Harger JH; Kuller JA
    J Reprod Med; 1994 Jun; 39(6):467-72. PubMed ID: 7932402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ampicillin/Sulbactam vs. Cefoxitin for the treatment of pelvic inflammatory disease.
    Jemsek JG; Harrison F
    Infect Dis Obstet Gynecol; 1997; 5(5):319-25. PubMed ID: 18476179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Italian experience of sequential intravenous and oral azithromycin plus intravenous ampicillin/sulbactam in hospitalized patients with community-acquired pneumonia.
    Todisco T; Dal Farra F; Ciliberti G; Pirina P; Guelfi R; Serra G; Paris R; Mancuso I; Cepparulo M
    J Chemother; 2008 Apr; 20(2):225-32. PubMed ID: 18467250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.
    Betrosian AP; Frantzeskaki F; Xanthaki A; Douzinas EE
    J Infect; 2008 Jun; 56(6):432-6. PubMed ID: 18501431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sultamicillin in the treatment of obstetric and gynaecological infections.
    Samaha I; Said A
    J Int Med Res; 1992; 20 Suppl 1():62A-70A. PubMed ID: 1451931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peritonsillar abscess: a comparison of outpatient i.m. clindamycin and inpatient i.v. ampicillin/sulbactam following needle aspiration.
    Ozbek C; Aygenc E; Unsal E; Ozdem C
    Ear Nose Throat J; 2005 Jun; 84(6):366-8. PubMed ID: 16075861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical efficacy of sulbactam/ampicillin in the treatment of moderately severe bacterial infections.
    Fong KY; Howe HS; Boey ML; Feng PH
    Singapore Med J; 1989 Apr; 30(2):170-2. PubMed ID: 2609176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The clinical diagnosis and treatment of ascending infections of the genitalia by using the combined preparation ampicillin/sulbactam (Unasyn)].
    Eibach HW
    Antibiot Khimioter; 1991 Jun; 36(6):13-5. PubMed ID: 1832852
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical experience with intramuscular sulbactam/ampicillin in the outpatient treatment of various infections. A multicentre trial.
    Güneren MF
    Drugs; 1988; 35 Suppl 7():57-68. PubMed ID: 3065055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A clinical trial with ampicillin and sulbactam in various infections].
    Kanra G; Seçmeer G; Tarim OF; Calikoğlu AS; Ecevit Z; Günel M
    Mikrobiyol Bul; 1988; 22(4):284-95. PubMed ID: 3252119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulbactam/ampicillin versus cefoxitin in the treatment of obstetric and gynaecological infections.
    Senft HH; Stiglmayer R; Eibach HW; Koerner H
    Drugs; 1986; 31 Suppl 2():18-21. PubMed ID: 3013568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections.
    Betrosian AP; Douzinas EE
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1099-112. PubMed ID: 19621991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.